Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation |
---|---|---|---|---|
16:00-16:15 | 16:00-16:15 |
Interaction of Diabetic Nephropathy and ASCVD in Diabetes |
Hang Li | |
16:15-16:22 | 16:15-16:22 |
Discussion |
||
16:22-16:37 | 16:22-16:37 |
Clinical Evidence of the Renal Benefits of GLP-1RA |
Pei Yu | |
16:37-16:44 | 16:37-16:44 |
Discussion |
||
16:44-16:59 | 16:44-16:59 |
Clinical Evidence of the Renal Benefit of SGLT2i |
Yan Qin | |
16:59-17:06 | 16:59-17:06 |
Discussion |
||
17:06-17:21 | 17:06-17:21 |
Potential Mechanism of the Cardiovascular Benefits of GLP-1RA & SGLT2i: A Renal-Centric Standpoint |
Zhihong Wang | |
17:21-17:30 | 17:21-17:30 |
Discussion |